Transcatheter Interventions Online 2024 - On Demand
Published: 20 March 2024
-
Views:
2801
-
Likes:
7
-
Views:
2801
-
Likes:
7
-
Up Next
-
3m 9sPart 2 | Session 1 Day Welcome: Complex PCI -
51m 36sPart 2 | Session 2 Session 2.1: Coronary Calcifications Updates -
1h 5m 33sPart 2 | Session 3 Session 2.2: Live Cases & Discussions -
58m 49sPart 2 | Session 4 Session 2.3: Imaging Focus -
1h 5m 56sPart 2 | Session 5 Session 2.4: Live Cases & Discussions -
3m 57sPart 2 | Session 6 Day Two Close
-
2mPart 3 | Session 1 Day Welcome: Debates & Controversies -
1h 1m 13sPart 3 | Session 2 Session 3.1: Keynote & Debates -
55m 15sPart 3 | Session 3 Session 3.2: Live Cases & Discussions -
59m 46sPart 3 | Session 4 Session 3.3: Controversies -
4m 16sPart 3 | Session 5 Day Three Close
-
3m 36sPart 1 | Session 1 Day Welcome: Structural Heart Disease Nicolas M Van Mieghem, Kendra J Grubb, Roxana Mehran, Ajay J Kirtane, David Hildick-Smith, Holger Thiele
-
59m 1sPart 1 | Session 2 Session 1.1: New Perspectives on Transcatheter Atrioventricular Valve Interventions Nicolas M Van Mieghem, Ole De Backer, Kendra J Grubb, Azeem Latib, Didier Tchétché
-
59m 33sPart 1 | Session 3 Session 1.2 Live Cases & Discussions Nicolas M Van Mieghem, Ole De Backer, Kendra J Grubb, Azeem Latib
-
39m 31sPart 1 | Session 4 Session 1.3: Revalving for Transcatheter Heart Valve Failure Kendra J Grubb, Nicolas M Van Mieghem, Giuseppe Tarantini, Holger Thiele, David Hildick-Smith
-
50m 48sPart 1 | Session 5 Session 1.4: Live Cases & Discussions Kendra J Grubb, Giuseppe Tarantini, Holger Thiele, David Hildick-Smith
Overview
TIO 2024 brought together an outstanding international faculty, creating an unparalleled interactive experience that will keep the global interventional cardiology community up-to-date with the latest advancements in transcatheter treatment strategies. Featuring a combination of expert opinions, engaging discussions, insightful presentations and live cases from prominent medical centres on both sides of the Atlantic, TIO delivered the highest-quality CME-accredited education.
Related Content:
Key Learning Objectives
- Review planning and valve selection strategies in patients with prior valve failure
- Summarise recent repair and replacement data in mitral and tricuspid regurgitation
- Select suitable tools for undertaking PCI in calcified lesions
- Optimise use of imaging in daily practice
- Outline the pros and cons of using P2Y12 inhibitors universally following PCI
- Identify situations where an IVUS or OCT-guided approach are preferable
- Discuss the possible implications of TAVR becoming a care option in asymptomatic aortic stenosis
Target Audience
- Interventional Cardiologists
- Surgeons with an interest in transcatheter treatment strategies for coronary and structural heart disease
- Interventional Cardiology Nurses
More from this programme
Part 1
Day One: Structural Heart Disease
Part 2
Day Two: Complex PCI
Part 3
Day Three: Debates & Controversies
Faculty Biographies
Kendra J Grubb
Surgical Director
Dr Kendra Grubb is the surgical director of the Emory Structural Heart and Valve Center. She is also an associate professor of surgery at Emory University School of Medicine.
Kendra is a champion for women's heart disease and is dedicated to improving the lives of all patients through innovation, collaboration and a patient-centred approach to the treatment of cardiovascular disease.
Her clinical interests include valve repair or replacement, coronary artery bypass graft surgery (CABG), transcatheter aortic valve replacement (TAVR) and hybrid coronary revascularization.
Dr Grubb research interests are innovative cardiac surgery technologies. She has led and participated in multiple clinical trials of innovative cardiac surgery technologies, including studies of transcatheter aortic valve replacement (TAVR), MitraClip percutaneous therapy and the GORE® conformable TAG® thoracic endoprosthesis for the primary treatment of…
Comments